Results 241 to 250 of about 68,751 (311)

Comparative effectiveness of omalizumab in asthma-COPD overlap vs. asthma: a retrospective cohort study. [PDF]

Front Med (Lausanne)
Sun H, Gu Y, Wang Y, Chen L, Guo B, Song X, Song F, Xie S.   +7 more
europepmc   +1 more source

Advances in the Association Between the <i>ADRB2</i> Gene and Bronchial Asthma: Genetic Polymorphisms, Epigenetic Regulation, and Clinical Applications. [PDF]

Curr Issues Mol Biol
Sun X, Li Y, Bao Y.
europepmc   +1 more source

Cleaning products and classes associated with poor respiratory health. [PDF]

Environ Sci Pollut Res Int
Dai X, Abramson MJ, Hamilton GS, Thompson BR, Svanes C, Benke G, Kaushik S, Dharmage SC, Lodge CJ.   +8 more
europepmc   +1 more source

Mapping the trajectory from pre-COPD to COPD: predictive value of symptoms, imaging, and physiologic abnormalities. [PDF]

Ann Am Thorac Soc
Zhang N, Gargurevich N, Murray S, Bosma CB, Curtis JL, Martinez FJ, Han MK, Labaki WW.   +7 more
europepmc   +1 more source

Bronchodilators

Dr. Dev Pankajkumar Mishra, Dr, Kirtan Chandulal Limbani, Dr. Manan Mahendrabhai Patel   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypoxic bronchodilation

Journal of Applied Physiology, 1992
Recent advances in computed tomographic imaging provide a unique method to serially and directly visualize acute physiological response in the lung. To directly investigate the airway response to hypoxia, high-resolution computed tomographic scans of the lungs of eight intact anesthetized minipigs were serially repeated before, during, and after ...
R C, Wetzel, C J, Herold, E A, Zerhouni, J L, Robotham   +3 more
openaire   +2 more sources

New bronchodilators

Current Opinion in Pharmacology, 2012
Bronchodilators are central in the treatment of airway diseases including chronic obstructive pulmonary disease (COPD). Bronchodilators in COPD aim to improve lung function, reduce symptoms, prevent exacerbation, and enhance quality of life. The majority of programs in development for novel bronchodilators are focused on enhancing existing targets to ...
Garbo, Mak, Nicola A, Hanania
openaire   +2 more sources

Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

, 1994
Objective. —To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV 1 ) in smokers aged 35 to 60 years who have mild obstructive ...
N. Anthonisen, J. Connett, J. Kiley, M. Altose, W. Bailey, A. Buist, W. Conway, P. Enright, R. Kanner, P. O'hara, G. Owens, P. Scanlon, D. Tashkin, R. Wise, M. Altose, A. Connors, S. Redline, C. Deitz, R. Rakos, W. Conway, A. DeHorn, J. Ward, C. Ryan, R. L. Jentons, J. Reddick, C. Sawicki, R. Wise, S. Permutt, C. Rand, P. Scanlon, L. J. Davis, R. Hurt, R. D. Miller, D. Williams, G. Caron, G. Lauger, S. Toogood, A. Buist, W. Bjornson, L. Johnson, W. Bailey, C. M. Brooks, J. Dolce, D. Higgins, Marvin Johnson, C. Lorish, B. Martin, D. Tashkin, A. Coulson, H. Gong, P. Harber, Volker Roth, M. Roth, M. Nides, M. Simmons, I. Zúñiga, N. Anthonisen, J. Manfreda, R. Murray, S. Rossum, J. M. Stoyko, J. Connett, M. Kjelsberg, M. Cowles, D. Durkin, P. Enright, K. Kurnow, W. W. Lee, P. Lindgren, S. Mongin, P. O'hara, H. Voelker, L. Waller, G. Owens, R. Rogers, J. J. Johnston, F. Pope, F. Vitale, R. Kanner, M. Rigdon, K. C. Benton, P. M. Grant, M. Becklake, B. Burrows, P. Cleary, P. Kimbel, L. Nett, J. Ockene, R. M. Senior, G. Snider, W. Spitzer, O. Williams, S. Hurd, J. Kiley, M. C. Ayres, S. Ayres, R. Hyatt, B. A. Mason   +97 more
semanticscholar   +1 more source